Biologicals in the treatment of severe asthma in children: A PERMEABLE assessment of the current practice in Europe

M. Kabesch (Regensburg, Germany), H. Buntrock-Döpcke (Regensburg, Germany), J. Niggel (Regensburg, Germany), K. Golebski (Amsterdam, Netherlands), C. Van Drunen (Amsterdam, Netherlands), S. Reinarts (Hilversum/Blaricum, Netherlands), U. Potocnik (Maribor, Slovenia), E. Melén (Stockholm, Sweden), A. Maitland-Van Der Zee (Amsterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands)

Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Session: Novel mechanisms and management of paediatric asthma
Session type: E-poster session
Number: 1205
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kabesch (Regensburg, Germany), H. Buntrock-Döpcke (Regensburg, Germany), J. Niggel (Regensburg, Germany), K. Golebski (Amsterdam, Netherlands), C. Van Drunen (Amsterdam, Netherlands), S. Reinarts (Hilversum/Blaricum, Netherlands), U. Potocnik (Maribor, Slovenia), E. Melén (Stockholm, Sweden), A. Maitland-Van Der Zee (Amsterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands). Biologicals in the treatment of severe asthma in children: A PERMEABLE assessment of the current practice in Europe. 1205

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: